Nanogel or kit for highly sensitive detection of target substances by surface-enhanced Raman scattering and detection method
The use of pH-responsive nanogels and magnetic nanoparticles with a 2D hexagonal boron nitride substrate enhances SERS detection by protecting and releasing nanotags, addressing instability issues and improving sensitivity and reproducibility in complex environments.
Patent Information
- Application Number
- JP2021001391
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-01-07
- Publication Date
- 2024-11-28
- Estimated Expiration
- 2041-01-07
AI Technical Summary
Conventional SERS nanotags with thick and hard protective layers face issues of instability, aggregation, and reduced efficiency due to mechanical and chemical deformation, especially in complex clinical samples, limiting their sensitivity and reproducibility in pathogen detection.
Employing pH-responsive nanogels to encapsulate and release SERS nanotags, combined with magnetic nanoparticles and a 2D hexagonal boron nitride substrate, to create controlled 'hot spots' for enhanced Raman scattering detection, utilizing stimuli-responsive nanogels to protect and release SERS nanotags effectively.
The method provides highly sensitive and stable detection of target substances by creating efficient 'hot spots', enabling detection of various target substances, including viruses and bacteria, with high specificity and selectivity even in complex samples.
Smart Images

Figure 0007591260000001 
Figure 0007591260000002 
Figure 0007591260000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a nanogel or a kit and a detection method for highly sensitive detection of a target substance by surface-enhanced Raman scattering. [Background technology]
[0002] When light is irradiated onto a material, the interaction between the light and the material causes scattering in addition to reflection, refraction, and absorption. There are two types of scattered light: Rayleigh scattering, in which light of the same wavelength as the incident light is scattered, and Raman scattering, in which light is scattered at a wavelength different from the incident light due to molecular vibrations. The wavelength difference between the incident light and the Raman scattered light corresponds to the energy of the molecular vibrations of the material, so the Raman spectrum obtained by dispersing the Raman scattered light can be used to analyze molecular level structure, concentration, etc. In other words, this is analysis using Raman spectroscopy.
[0003] However, Raman scattering is unstable and is 10 times slower than Rayleigh scattering. -6 Because the light emitted by the Raman scattering is about 100 times weaker than that emitted by the noble metal nanostructure, surface-enhanced Raman scattering (SERS) was developed as a technology to enhance the light (Non-Patent Documents 1 and 2). SERS refers to the phenomenon in which the Raman scattered light from molecules bound to a noble metal nanostructure is enhanced by hundreds of millions of times. The incident light, a Raman laser, generates surface plasmons on the surface of the noble metal nanostructure, and the surface plasmons interact with the bound molecules to greatly amplify the Raman signal of the bound molecules, i.e., surface plasmon resonance.
[0004] Surface-enhanced Raman scattering (SERS) spectroscopy is known as an effective platform for next-generation diagnostics of pathogens through the "hot spot" containing two / three-dimensional (2D / 3D) nanostructures (Non-Patent Document 1). SERS-based pathogen detection consists of a composite system of target antigens, SERS nanotags, and SERS substrates that create "hot spot" regions (Non-Patent Documents 1, 3). Therefore, the sensitivity and reproducibility of SERS-based immunoassays depend on the stability of the SERS nanotags and SERS substrates.
[0005] In immunoassays, it is essential to pretreat or isolate the target antigen from the sample matrix. Clinical samples often contain complex matrices that may cause non-specific interactions with SERS nanotags (Non-Patent Documents 4, 5). Nanotags also exhibit unstable and irreproducible signals in high ionic strength solutions (Non-Patent Document 6). As a result, the instability, structural aggregation and chemical distortion of nanotags have been pointed out as significant drawbacks in SERS detection, especially for clinical samples with high impurities.
[0006] To address this, it has been proposed that SERS nanotags are covered with hard silica coatings and polymers as protective shells / layers (Non-Patent Document 7). The aim is to prevent the SERS nanotags from undergoing mechanical and chemical deformation, as well as to maintain their integrity by reducing aggregation and ensuring stability in complex environments (Non-Patent Documents 8-10). The biocompatibility and non-toxicity of SERS nanotags have also been improved by this strategy (Non-Patent Document 11).
[0007] Although this strategy is very useful in SERS-based immunoassays and imaging, the large dimensions and magnetic impermeability due to the thickness and rigidity of the protective shell / layer, coupled with the complicated encapsulation process, limit the convenient use of this strategy. (7, 12) Furthermore, since the SERS nanotags are immobilized in a thick and rigid protective layer, it tends to hinder the light-matter interaction required for Raman activity, which may limit the efficiency of the performance of the SERS nanotags.
[0008] On the other hand, three-dimensional nanogels are soft polymeric nanomaterials with tunable frameworks and internal cavities (Non-Patent Document 13). Nanogels are typically used as payloads / protective shells for in vivo delivery in biomedical applications (Non-Patent Document 14). Due to their flexible chemical structure, nanogels can be tailored to respond to specific stimuli (pH, temperature or light), thereby enabling stimulus-triggered release of encapsulated substances (Non-Patent Document 15). [Prior art documents] [Non-patent literature]
[0009] [Non-Patent Document 1] Lee, HK, Lee, YH, Koh,CSL, Phan-Quang, GC, Han, X., Lay, CL, Sim, HYF, Kao, YC, An, Q.,Ling, XY, 2019. Chem. Soc. Rev. 48, 731-756. [Non-Patent Document 2] Porter, MD, Lipert, RJ,Siperko, LM, Wang, G., Narayanan, R., 2008. Chem. Soc. Rev. 37, 1001-1011. [Non-Patent Document 3] Kaminska, A., Witkowska, E., Winkler, K., Dziecielewski, I., Weyher, JL, Waluk, J., 2015. Biosens.Bioelectron. 66, 461-467. [Non-Patent Document 4] Neng, J., Harpster, MH, Wilson,WC, Johnson, PA, 2013. Biosens. Bioelectron. 41, 316-321. [Non-Patent Document 5] Sun, Y., Xu, L., Zhang, F., Song,Z., Hu, Y., Ji, Y., Shen, J., Li, B., Lu, H., Yang, H., 2017. Biosens.Bioelectron. 89, 906-912.
Non-licensed Document 6
Non-licensed Document 7
Non-licensed literature 9
Non-licensed literature 10
Non-licensed Document 11
Non-licensed Document 12
[0010] In view of the problems associated with the thick and hard protective layer of conventional SERS nanotags, the present invention aims to provide a nanogel for highly sensitive detection of target substances by surface-enhanced Raman scattering, a kit containing the nanogel, and a detection method based on surface-enhanced Raman scattering using the same. [Means for solving the problem]
[0011] As a result of extensive research, the inventors have discovered that by using a pH-responsive nanogel to encapsulate / release a SERS nanotag into the pH-responsive nanogel, they can protect the SERS nanotag from chemical deformation, and further, by binding a specific antibody for the target substance to the surface of the pH-responsive nanogel, they have succeeded in efficiently creating a "hot spot" for SERS, thereby discovering a method for detecting the target substance with high sensitivity, and have completed the present invention.
[0012] That is, the present invention is as follows. [1] A nanogel for detecting a target substance based on surface-enhanced Raman scattering (SERS), the nanogel containing a SERS nanotag therein, a specific probe for the target substance bound to the surface of the nanogel, and capable of releasing the nanotag outside the nanogel in response to a physical or chemical stimulus. [2] The nanogel described in [1], wherein the physical or chemical stimulus is selected from pH, temperature, and light. [3] The nanogel according to [1] or [2], wherein the target substance is selected from proteins, nucleic acids, sugars, bacteria and viruses. [4] The nanogel according to any one of [1] to [3], wherein the target substance is a virus or a bacterium. [5] The nanogel according to any one of [1] to [4], wherein the probe is selected from an antibody, a nucleic acid probe, a lectin, and an aptamer. [5] The nanogel according to any one of [1] to [6], for detecting a target substance in a test sample selected from urine, stool, blood, saliva, other body fluids, mucous membranes, hair, cells, and tissues. [7] The nanogel according to any one of [1] to [6], wherein the SERS nanotag is a molybdenum trioxide quantum dot having 4-mercaptobenzoic acid bound to its surface. [8] A nanogel according to any one of [1] to [7], Surface-modified magnetic nanoparticles bound with specific probes for the target substance. 1. A kit for surface-enhanced Raman scattering (SERS)-based detection of a target substance, comprising: [9] The kit according to [8], further comprising a two-dimensional substrate having a surface coated with hexagonal boron nitride.
[10] A method for detecting a target substance based on surface-enhanced Raman scattering (SERS), using the nanogel according to any one of [1] to [7], or the kit according to [8] or [9].
[11] (1) A step of preparing a nanogel according to any one of [1] to [7] and magnetic nanoparticles that have been surface-modified and bound with a specific probe for the target substance; (2) contacting the nanogel and the magnetic nanoparticles with a sample that may contain the target substance to form a reaction complex containing the target substance, the nanogel, and the magnetic nanoparticles; (3) recovering the reaction complex using a magnet; (4) applying a physical or chemical stimulus to the reaction complex to release the SERS nanotags from the nanogel and form SERS hotspots; (5) subjecting the reaction complex in which the SERS hotspot is formed to a Raman scattering analysis on a SERS substrate to detect the presence of the target substance; The detection method according to
[10] , comprising:
[12] The detection method according to
[11] , wherein the physical or chemical stimulus to the reaction complex is selected from pH, temperature, and light.
[13] The detection method according to
[11] or
[12] , wherein the SERS substrate is a two-dimensional substrate whose surface is coated with hexagonal boron nitride.
[14] (6) The detection method according to any one of
[11] to
[13] , further comprising a step of quantifying the target substance with reference to a calibration curve previously prepared using a standard of the target substance. Effect of the Invention
[0013] The flexible and stimuli-responsive nanogel of the present invention can trap SERS nanotags inside, protecting them from chemical deformation, and then after separation, concentration, and purification of target antigens, the SERS nanotags can be released from the nanogel upon stimulation, creating very effective "hot spots."
[0014] The present invention can also provide a highly sensitive detection method based on SERS that utilizes a specific reaction (e.g., antigen-antibody reaction) between a target substance and a probe. In the detection method of the present invention, by using magnetic nanoparticles with specific functional groups in addition to the nanogel of the present invention, the reaction complex can be efficiently separated and concentrated after the specific reaction between the target substance and the probe, and further, by binding the functional groups of the magnetic nanoparticles to the SERS tag, a "hot spot" can be generated. Since the detection method of the present invention has high specificity, selectivity, and stability, it can detect various target substances containing complex components with high sensitivity. [Brief description of the drawings]
[0015] [Figure 1] (A) shows the preparation scheme of SERS nanotags using MoO3-QDs and 4-MBA, and (B) shows a schematic diagram of the preparation scheme of Immuno-mal-CmagNPs by localization of nanotags via thiol-maleimide affinity and the formation scheme of SERS “hot spots.” [Diagram 2] Schematic diagram of the nanogel-based chemical payload system for SERS nanotag encapsulation / protection (SERS nanotag@NG) and schematic diagram of SERS “hot spot” formation and highly sensitive immunoassay of target viruses, pH-triggered release of SERS nanotags, and SERS detection. [Diagram 3] (a) shows the XPS wide scan spectrum of MoO3-QDs, and (b) shows the high-resolution XPS spectrum of Mo 3d. [Figure 4] (a) is a TEM image of MoO3-QDs, and (b) is a size (particle diameter) distribution graph of MoO3-QDs. [Diagram 5] The UV-vis absorption spectrum of MoO3-QDs is shown. [Figure 6](a) Schematic diagram showing pH-responsive nanogel (NG), (b) TEM image of untreated NG at pH 7.0, (c) TEM image of NG loaded with SERS nanotags (SERS nanotag@NG) at pH 7.4, and (d) TEM image showing the release of SERS nanotags (4-MBA-MoO3-QDs) at pH 4.5. [Figure 7] (a) shows the measurement results of the transition hydrodynamic diameter (Dh) of NG at pH 4 to 9, and (b) shows the measurement results of the hydrodynamic volume (Vh) of NG at pH 4 to 9. [Figure 8] (a) shows the DLS plots of NGs loaded with SERS nanotags and untreated NGs (blank NGs), and (b) shows the UV-vis spectra of the SERS nanotags alone and when the SERS nanotags are encapsulated in NGs at pH 7.4. [Figure 9] 1 shows the SERS spectra of nanotags formed in the presence of maleimide-functionalized CmagNPs (mal-CmagNPs) or CmagNPs that do not contain a maleimide moiety. [Figure 10] (a) shows the results (Raman scattering intensity) of hepatitis E virus-like particle (HEV-LP) detection using NG carrying SERS nanotags when different concentrations of HEV-LP were added, and (b) shows the results (calibration curve based on Raman scattering intensity) of detection of HEV-LP in PBS or human serum when a 2D hexagonal boron nitride (h-BN) substrate was used as the detection platform (the scale bar in the figure indicates a Raman scattering intensity of 10,000). [Figure 11] (a) shows the detection results of HEV-LP in PBS on a bare glass substrate (calibration curve based on Raman scattering intensity), and (b) shows the detection results of HEV (G7HEV) in clinical samples using a 2D h-BN substrate or a bare glass substrate as the detection platform (calibration curve based on Raman scattering intensity). [Figure 12](a) shows the detection of Norovirus (NoV) in fecal samples from infected patients using the SERS-based immunoassay of the present invention (calibration curve based on Raman scattering intensity) and a commercial ELISA (calibration curve based on absorption intensity), and (b) shows the specific and selective detection of HEV-LP in the presence of other viruses and virus-like particles as potential interfering biomolecules. [Figure 13] (a) shows an optical image of the SERS detection substrate (h-BN) and the mapping of 100 random spots, (b) shows photographs of the 2D h-BN and Si substrates, (c) shows the SERS signal of 100 different mapped spots and the relative standard deviation showing the spot-to-spot variation and reproducibility of the immunoassay at 1098 cm-1, and (d) shows the SERS spectrum of overlapping SERS nanotags in 100 randomly distributed spots. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0016] The detection method of the present invention is a detection method by a specific reaction of a target substance-probe based on surface-enhanced Raman scattering (SERS). A typical example of a specific reaction of a target substance-probe is an antigen-antibody reaction (immune reaction), but other specific reactions of a target substance-probe function in the same way, so the specific reaction of a target substance-probe may be explained below using an antigen-antibody reaction as an example. In order to increase the detection sensitivity, it is important for SERS detection to generate a "hot spot" with a high plasmon electric field intensity. The innovative detection method of the present invention uses a nanogel that is responsive to physical or chemical stimuli to encapsulate (protect) and release SERS nanotags, thereby enabling controlled release and creating a hot spot.
[0017] The detection method of the present invention is further characterized by binding a specific probe (e.g., a specific antibody) for a target substance to the surface of the nanogel, and using magnetic nanoparticles bound with a specific probe (e.g., a specific antibody) for the same target substance, whereby both the magnetic nanoparticles and the nanogel bind to the target substance to form a sandwich-structured reaction complex (e.g., an immune complex). The reaction complex can be easily separated and concentrated by magnetism, making it possible to detect with high sensitivity even from clinical samples containing complex components.
[0018] The detection method of the present invention is further characterized in that the magnetic nanoparticles are functionalized so that they can bind to SERS nanotags. By applying a physical or chemical stimulus to the separated and concentrated reaction complex, the SERS nanotags are released from the nanogel and further bound to the magnetic nanoparticles, forming SERS hot spots around the nanogel, enabling the target substance to be detected with high sensitivity.
[0019] Moreover, the present invention also provides a SERS substrate suitable for SERS detection, which can further improve the detection sensitivity of target substances.
[0020] The SERS nanotag, nanogel, SERS substrate, kit and detection method of the present invention will be described in detail below.
[0021] [SERS nanotags] The SERS nanotag of this embodiment may be any nanotag that has SERS activity. The SERS nanotag may be any nanotag that has a surface plasmon effect, such as plasmonic metal quantum dots containing metals such as gold, silver, copper, and molybdenum, and preferably molybdenum trioxide quantum dots (MoO 3 Molybdenum trioxide quantum dots (MoO) with 4-mercaptobenzoic acid (4-MBA) bonded to their surface. 3 -QD), where the bond is the linkage between the 4-MBA functional group and MoO 3 - means that it is bonded to QD.
[0022] SERS is a laser-based optical spectroscopy technique that produces fingerprint-like vibrational spectra of molecules with much narrower features than typical fluorescence. Raman scattering can be excited using a wide range of wavelengths, including monochromatic far-red or near-infrared light, and its photon energy is so small that it does not excite the inherent background fluorescence in biological samples. Raman spectra are generally measured in the range of 300–3500 cm -1 It is possible to cover vibration energies of up to 1000 Hz.
[0023] The SERS nanotag of the present invention has a wavelength of 300 to 3500 cm -1 Any vibrational spectrum that exhibits a characteristic vibrational energy range may be used, and preferably, the vibrational energy range is 1000 to 1700 cm -1 A plasmonic metal quantum dot is a quantum dot to which a molecule that exhibits a characteristic vibration spectrum in the vibrational energy range of 4-MBA is bonded. 3 -QD is 1098cm -1 In addition, rhodamine 6G or 4-aminothiophenol can also be used.
[0024] The particle size of the SERS nanotag may be the same as that of a general quantum dot, for example, 1 nm to 100 nm, or 1 nm to 50 nm, or 1 nm to 20 nm. It is preferable that the particle size is uniform.
[0025] Plasmonic metal quantum dots can be prepared by known methods. For example, MoO 3 In the case of MoO-QDs, they may be synthesized according to the method of Zu et al. (Zu, H., et al., 2018. New J. Chem. 42, 18533-18540) or, as an improvement of the method of Zu et al., may be synthesized using a hydrothermal process as described in the Examples. 3The method of attaching 4-MBA to the surface of -QDs can be prepared by known methods, for example, following a two-step procedure involving silanization with 3-aminopropyltriethoxysilane (APTES) and carbodiimide chemistry (EDC / NHS).
[0026] [Nanogel] The nanogel of this embodiment is a nanogel for detecting a target substance based on surface-enhanced Raman scattering (SERS), which contains a SERS nanotag inside, has a specific antibody for the target substance bound to the surface of the nanogel, and can release the nanotag outside the nanogel in response to a physical or chemical stimulus. Here, "containing a SERS nanotag inside" is often expressed as "encapsulated" in this specification. Moreover, the SERS nanotag here can be the SERS nanotag of the present invention described above.
[0027] The nanogel of this embodiment is not particularly limited as long as it is a nanogel that is stimuli-responsive. Here, stimuli-responsive means that the permeability of the nanogel can change when it receives a physical or chemical stimulus. By changing the permeability of the nanogel, it becomes possible to encapsulate a substance (SERS nanotag) present around the nanogel in the nanogel, or to release the substance encapsulated in the nanogel to the surroundings. Therefore, by controlling the physical or chemical stimulus, it is possible to protect the SERS nanotag, or to control the timing of release and reaction.
[0028] The physical or chemical stimulus is preferably selected from pH, temperature, and light from the viewpoint of ease of control. Those skilled in the art can select an appropriate stimulus-responsive nanogel depending on the target substance to be measured and its antibody. From the viewpoint of ease of control, a pH-responsive nanogel is preferably used. Examples of pH-responsive nanogels include nanogels that are responsive in the pH range of 4 to 9. Among them, a pH-responsive nanogel obtained by crosslinking a glutaraldehyde (GA) microemulsion described in the Examples is preferably used.
[0029] The pH-responsive nanogel is stable in the neutral range (pH 7.0-8.0), and in this pH range, especially at physiological pH (7.4), it does not release the SERS nanotags encapsulated in the cavities of the nanogel. On the other hand, at weakly acidic pH (pH 4-5, especially pH 4.5), the structure of the nanogel changes, and the nanotags encapsulated in the nanogel can be released or taken up by the nanotags present in the surroundings. After the nanogel is taken up, the pH is returned to neutral, and the nanotags can be encapsulated and protected in the nanogel. The encapsulation of the nanotags in the nanogel can be confirmed, for example, by TEM, and the release can also be observed by TEM. Furthermore, when the SERS nanotags are encapsulated in the nanogel, their characteristic Raman scattering is blocked by the nanogel, so that the encapsulation of the SERS nanotags can also be confirmed by Raman scattering analysis.
[0030] A specific probe (e.g., a specific antibody) for the target substance is bound to the surface of the nanogel of this embodiment. This is for detection based on a specific reaction (e.g., an antigen-antibody reaction) between the nanogel and the target substance. The specific probe for the target substance is as described below. The specific probe such as an antibody can be bound to the nanogel according to a known method. For example, the method described in the Examples can be mentioned.
[0031] [Magnetic Nanoparticles] The magnetic nanoparticles of this embodiment are surface-modified and bound with a specific antibody against a target substance. The surface modification of the magnetic nanoparticles is preferably a modification group that can react with and bind to a molecule (e.g., 4-MBA) bound to a SERS nanotag. Examples of surface-modified magnetic nanoparticles include maleimide-functionalized magnetic nanoparticles. The antibody here is a specific antibody against the target substance, and may be the same as the antibody bound to the nanogel, or may be a different antibody.
[0032] The magnetic nanoparticles may be any nanoparticle that has enough magnetism to be attracted and separated by a normal magnet. For example, Fe 2 O 3 , Fe 3 O 4 , CoFe 3 O 4 The magnetic nanoparticles may be nanoscale particles of magnetic materials such as ferromagnetic nanoparticles, etc. Also, the magnetic nanoparticles are preferably functionalized to bind probes such as antibodies, e.g., when the probe is an antibody, the magnetic nanoparticles are preferably carboxylated.
[0033] The particle diameter of the magnetic nanoparticles may be 3 nm to 50 nm, for example, 3 nm to 20 nm, or 3 nm to 10 nm.
[0034] The magnetic nanoparticles can be prepared according to known methods. The carboxylation of the magnetic nanoparticles and the binding of the antibody to the carboxylated magnetic nanoparticles can also be performed according to known methods. Specifically, the methods described in the Examples can be mentioned. [SERS substrate] The SERS substrate of this embodiment is preferably a two-dimensional substrate whose surface is coated with hexagonal boron nitride (h-BN) (hereinafter referred to as a "hexagonal boron nitride substrate" or "h-BN substrate"). The h-BN substrate is preferably a two-dimensional (2D) substrate, and may be referred to as a "2D h-BN substrate" hereinafter.
[0035] SERS measurements performed on 2D h-BN substrates showed that the h-BN SERS activity increased the SERS intensity by approximately 10 times compared to the substrate without h-BN coating. 3 The signal can be enhanced by up to an order of magnitude, so that even if the amount of the target substance is small, it can be detected with high sensitivity.
[0036] The 2D h-BN substrate can be prepared, for example, by dropping and immobilizing a h-BN dispersion onto bare glass. Specifically, the method described in the Examples can be mentioned. 〔kit〕 The kit of this embodiment is a kit for detecting a target substance based on surface-enhanced Raman scattering (SERS), which includes the nanogel of the present invention and the magnetic nanoparticles of the present invention. Furthermore, the kit of this embodiment preferably includes the SERS substrate of the present invention.
[0037] By using the kit of this embodiment and carrying out the detection method described below, a target substance can be detected with high sensitivity.
[0038] [Detection method] The method for detecting a target substance based on surface-enhanced Raman scattering (SERS) of the present invention is a detection method using the nanogel of the present invention or the kit of the present invention.
[0039] The detection method of this embodiment may include the following steps: A schematic diagram of one example of the detection method is shown in FIG. (1) preparing the nanogel of the present invention described above and magnetic nanoparticles having a surface modification and a specific probe for a target substance bound thereto; (2) contacting a nanogel and magnetic nanoparticles with a sample that may contain a target substance to form a reaction complex containing the target substance, the nanogel, and the magnetic nanoparticles; (3) recovering the reaction complex using a magnet; (4) applying a physical or chemical stimulus to the reaction complex to release the SERS nanotags from the nanogel and form SERS hotspots; and (5) A step of subjecting the reaction complex in which the SERS hot spot is formed to Raman scattering analysis on a SERS substrate to detect the presence of the target substance.
[0040] The nanogel and magnetic nanoparticles in step (1) are as described above.
[0041] The probe for the target substance is not particularly limited, and may be any substance that specifically binds to the probe. For example, one of a pair of substances that specifically bind to each other, such as antigen-antibody, sugar-lectin, ligand-receptor, aptamer target substance-aptamer, nucleic acid-nucleic acid, etc., can be used as the target substance and the other as the probe. For example, viruses, proteins, peptides, DNA, RNA, sugars, chemical substances, hormones, etc. can be used as the target substance or probe.
[0042] The target substance is preferably selected from proteins, nucleic acids (RNA or DNA), sugars, bacteria, and viruses, and is particularly preferably a virus or bacteria. Examples of viruses include hepatitis viruses (types A, B, C, D, E, F, G, and TT), influenza viruses, noroviruses, adenoviruses, cytomegaloviruses, white spot syndrome viruses (WSSV), rotaviruses, coronaviruses, dengue viruses, chikungunya viruses, and Japanese encephalitis viruses, which infect typical humans or non-human animals and are diagnosed using specific antibodies. The probe is preferably selected from antibodies, nucleic acid probes, lectins, and aptamers.
[0043] When a virus is the target substance, the antibody against the virus can be an antibody against a surface antigen of the virus. Known surface antigens of the virus include, for example, Genogroups 1 to 7 (G1 to G7) of Hepatitis E virus (HEV), hemagglutinin (HA) and neuraminidase (NA) of influenza virus, Genogroup I and Genogroup II of norovirus, etc.
[0044] The specific antibody can be produced by a known method, for example, by immunizing an animal such as a mouse, rabbit, or goat with a partial sequence peptide of a region specific to the target substance to collect antiserum, or by producing a hybridoma that produces the antibody. Alternatively, a commercially available antibody may be used. The antibody may be a polyclonal antibody, a monoclonal antibody, or a functional fragment thereof. One or more types of antibodies against the target substance may be used.
[0045] The target substance may be present in a liquid, or may be present in a solid, powder, fluid, gas, etc. Examples of test samples containing a target substance include urine, feces, blood, saliva, other body fluids, mucous membranes, hair, cells, tissues, etc. collected from humans or non-human animals. Blood includes whole blood, plasma, or serum. Other body fluids include mucus, gastric juice, intestinal fluid, etc. Since the test sample is preferably a liquid, when the target substance is present in a sample material other than a liquid, it is preferable to dissolve or suspend the sample material in an appropriate buffer or the like to make the sample into a liquid. In addition, in order to increase the detection sensitivity, it is preferable to purify the sample in advance to remove impurities and contaminants. On the other hand, as demonstrated in the examples, the detection method of the present invention has high detection characteristics and selectivity, and can detect the target substance in a test sample (biological sample) containing complex components with high sensitivity and specificity.
[0046] In step (2), the nanogel and magnetic nanoparticles are brought into contact with a sample that may contain a target substance to form a reaction complex containing the target substance, the nanogel, and the magnetic nanoparticles. For example, when the specific probe for the target substance is an antibody, the nanogel and magnetic nanoparticles are preferably brought into contact with the target substance under conditions (temperature, pH, contact time) that allow an appropriate immune reaction to occur in order to cause an antigen-antibody reaction. The contact is preferably carried out in a liquid. The nanogel and magnetic nanoparticles are preferably added in excess. The resulting immune complex has a sandwich structure of nanogel-target substance-magnetic nanoparticles.
[0047] In step (3), a magnet is used to collect the reaction complex (e.g., immune complex). The magnetic nanoparticles collected by the magnet include those to which the target substance and nanogel are bound. Meanwhile, excess nanogel that is not bound to the target substance is not collected. The collected reaction complex is preferably washed to remove non-specifically bound components before carrying out step (4).
[0048] In step (4), a physical or chemical stimulus is applied to the reaction complex (e.g., immune complex) to release the SERS nanotag from the nanogel and form a SERS hotspot. The release of the SERS nanotag from the nanogel is as described above. The SERS nanotag released from the nanogel binds to the surface modification of the magnetic nanoparticles, thereby forming a SERS hotspot (Figures 1 and 2).
[0049] In step (5), the reaction complex (e.g., immune complex) in which the SERS hotspot is formed is subjected to Raman scattering analysis on the SERS substrate to detect the presence of the target substance. In this case, the SERS substrate used is preferably the above-mentioned hexagonal boron nitride substrate. In this case, a magnet can be placed under the SERS substrate to guide the reaction complex to any position on the SERS substrate.
[0050] Furthermore, the detection method of this embodiment may further include the step of (6) quantifying the target substance with reference to a calibration curve previously prepared using a standard of the target substance.
[0051] The detection method of the present invention is not only capable of providing highly sensitive detection, but also can be adapted to various target substances by changing the antibody used, making it an extremely versatile detection method.
[0052] The present invention will be described in detail below with reference to examples, but the present invention is not limited to these examples in any way. EXAMPLES
[0053] <Measuring equipment> Confocal Raman spectroscopy and SERS analysis were performed on an NRS-7100 microscope mounted laser Raman spectrophotometer (JASCO, Tokyo, Japan) using a 785 nm laser. Measurements were performed with a 100× objective lens at 1% laser power and 2 s integration time. Multipoint SERS analysis was performed by fast mapping function in an area of 50 μm × 50 μm with a step size of 2 μm and an exposure time of 2 s. The laser power was 1% and the acquisition time was set to 1 s for each pixel.
[0054] X-ray photoelectron spectroscopy (XPS) analysis was performed on an ESCA1600 system (ULVAC-PHI Inc., Tokyo, Japan) using an Al Kα X-ray source (1486.6 eV) and a hemispherical analyzer.
[0055] Ground-state electronic absorption (UV / Vis) spectra were recorded on a filter-based multimode microplate reader (Infinite F200M; TECAN, Ltd., Mannedorf, Switzerland). Transmission electron microscopy (TEM) images were obtained using a JEM-2100F system (JEOL, Ltd., Tokyo, Japan) operated at 100 kV. Dynamic light scattering (DLS) and zeta potential analysis were performed using a Malvern Zetasizer Nano Series Nano-ZS90 system (Malvern Inst. Ltd., Malvern, UK). Powder X-ray diffraction (PXRD) analysis was performed using a RINT ULTIMA XRD system (Rigaku Co., Tokyo, Japan) with a Ni filter and a Cu-Kα source. Data were collected over 2θ = 10–90° at a scan rate of 0.01° / step and 10 s / point.
[0056] Fourier transform infrared spectroscopy was performed on an FT / IR-6300 spectrometer equipped with an ATR PRO610P-S (JASCO).
[0057] Enzyme-linked immunosorbent assay (ELISA) experiments were performed using a microplate reader (model 680; Bio-Rad, Hercules, California, USA).
[0058] <Reagents and Materials> Ammonium molybdate tetrahydrate, polyvinylpyrrolidone (PVP), and hydrogen peroxide (30%) were supplied by FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan). Glutaraldehyde, iron(III) chloride, 3-aminopropyltriethoxysilane (APTES), succinic anhydride, polyethyleneimine (PEI, branched average Mw 25,000), tannic acid, Triton X-100, bovine serum albumin (BSA), N-hydroxysuccinimide (NHS), and N-(3-dimethylaminopropyl)-N´-ethylcarbodiimide hydrochloride (EDC) were purchased from Sigma-Aldrich (St. Louis, USA). 4-Mercaptobenzoic acid (4-MBA) and N-(2-aminoethyl)maleimide hydrochloride were supplied by Tokyo Chemical Industry Co., Ltd. Hexagonal boron nitride (h-BN) powder was obtained from ACS Materials, LLC (California, USA). All experiments and solution preparations were carried out with ultrapure double-distilled deionized (DI) water (>18 MΩ cm) unless otherwise stated.
[0059] Human serum (from human male AB plasma, US origin, sterile filtered) was purchased from Sigma-Aldrich (St. Louis, USA). Zika virus was kindly provided by Professor Morita, Institute of Tropical Medicine, Nagasaki University. NoV-LP was prepared according to our conventional protocol. Influenza virus A (H1N1) (New Caledonia / 20 / 99) was purchased from Prospec-Tany TechnoGene Ltd. (Rehovot, Israel). Clinically isolated influenza virus A / Yokohama / 110 / 2009 (H3N2) was kindly provided by Dr. C. Kawakami, Yokohama City Institute of Health (Japan). Goat anti-rabbit IgG-HRP was purchased from Santa Cruz Biotechnology (Dallas, Texas, USA). Dengue virus cDNA was synthesized by Integrated DNA Technologies (Coralville, Iowa, USA). HEV-LP and rabbit anti-G3HEV IgG antibody were provided by Dr. Tiancheng Li of the National Institute of Infectious Diseases. The RNA copy number of G7HEV was 5.0 × 10 8 The number of copies / mL was 1000. A broadly reactive monoclonal antibody (NS14, isotype-IgG obtained from spleen cells of orally immunized mice) specific for Nov genogroup II was used in a sandwich immunoassay. GII.4 norovirus-like particles (NoV-LPs) were expressed and purified according to standard protocols for virus-like particle preparation. Clinical fecal samples from patients infected with gastroenteritis were provided by Mr. Fuyuki Abe of the Shizuoka Prefectural Environmental Health Research Institute. The samples were pretreated and quantified using RT-qPCR.
[0060] A commercial ELISA kit for NoV detection-NV EIA "Seiken" was supplied by Denka Co. Ltd., Tokyo, Japan. A paper-based lateral flow NoV antigen kit for rapid testing was provided by Sekisui Med. Co. Ltd. (Japan).
[0061] Example 1 Preparation of SERS nanotags, magnetic nanoparticles, nanogels, and h-BN substrates <MoO3 -Synthesis of QD> Plasmonic molybdenum trioxide quantum dots (MoO 3 -QD) were synthesized according to the method of Zu et al. (Zu, H., et al., 2018. New J. Chem. 42, 18533 - 18540), except for the improvement using a hydrothermal process.
[0062] Specifically, 0.1 g (0.08 mmol) of ammonium molybdate tetrahydrate was dissolved in a 20 mL mixture of deionized (DI) water and H 2 O 2 (5:3). Then, PVP (0.5 g) was added and stirred for 1 hour. The mixture was transferred to a Teflon - lined stainless - steel autoclave and heated at 180 °C for 4 hours. After cooling to room temperature, the obtained MoO 3 -QD was washed 4 times with ethanol and then 2 times with acetone, and dried at 600 °C for 12 hours.
[0063] <Fabrication of SERS nanotags> As shown in A of Figure 1, 4 - mercaptobenzoic acid (4 - MBA) and the above - synthesized MoO 3 -QD were used to fabricate SERS nanotags by a two - step procedure involving silanization with 3 - aminopropyltriethoxysilane (APTES) and carbodiimide chemistry (EDC / NHS).
[0064] Specifically, 2 mg of MoO 3 -QD was continuously stirred in 5 mL of a mixture of ethanol and toluene (1:1) for 12 hours, then 2 mg / mL of APTES was added to the mixture and refluxed at 90 °C for 12 hours. After that, the obtained NH 2 -functionalized MoO 3 -QD was repeatedly washed using toluene and then ethanol, and dried in vacuo at 60 °C. 4 - MBA was added to the NH 2 -functionalized MoO 3-To conjugate with QD, 5 mg of excess 4-MBA was stirred with a mixture of EDC (200 μL, 0.1 M) and NHS (100 μL, 0.1 M) in 5 mL of PBS (pH 7.6) for 1 h to activate the carboxyl groups of 4-MBA. Then, 3 mg of the prepared NH 2 -functionalized MoO 3 -QD was added to the resulting mixture and stirred for an additional 6 h to carbodiimide-bond the terminal NH 3 of MoO 2 -QD to the carboxylic acid groups of 4-MBA. Finally, the resulting product was centrifuged, washed three times with a mixture of ethanol and acetone (1:1), and dried under reduced pressure at 60 °C to obtain a novel SERS nanotag (4-MBA-MoO 3 -QD).
[0065] <Synthesis of Carboxylated Magnetic Nanoparticles (CmagNP)> Magnetic nanoparticles (magNP) were prepared according to the method of Zhang et al. (Zhang, Z.J., et al., 2014. J. Huazhong Univ. Sci. Technol. - Med. Sci. 34, 270-275). The obtained magNP was carboxylated using succinic anhydride according to the method of Safaei-Ghomi et al. (Safaei-Ghomi, J., et al., 2017. Ultrason Sonochem. 38, 488-495) to obtain carboxylated magnetic nanoparticles (CmagNP).
[0066] Specifically, 3 mg of the prepared magNP was dissolved in 10 mL of dehydrated toluene as the reaction medium, 0.2 mg of succinic anhydride was further added, and the mixture was refluxed at 120 °C for 6 h. Then, the obtained magNP with carboxylic acid terminals (CmagNP) was repeatedly washed three times with toluene and diethyl ether. The obtained CmagNP was collected by an external magnet and dried in vacuo at 60 °C.
[0067] <Preparation of Immuno-mal-CmagNP> As in the scheme shown in B of FIG. 1, the prepared CmagNP was simultaneously conjugated with an anti-HEV IgG antibody and a maleimide-containing compound using 1-ethyl-3-(-3-dimethylaminopropyl)carbodiimide / N-hydroxysuccinimide (EDC / NHS) carbodiimide chemistry.
[0068] Specifically, 0.1 M (5 mL) EDC was mixed with 2 mg of CmagNP in 1 mL of PBS (pH 7.6) and stirred for about 1 hour to generate an active ester intermediate having a carboxyl group of CmagNP. Then, 2 mL of 0.1 M NHS, 5.2 μg of anti-HEV IgG antibody, and N-(2-aminoethyl)maleimide (2 mL, 0.3 mmol) were simultaneously added to the activated CmagNP to simultaneously promote the carbodiimide chemical reaction between the carboxylic acid of CmagNP and the amino groups of the anti-HEV IgG antibody and N-(2-aminoethyl)maleimide. After the mixture was stirred at 4°C for 8 hours, the obtained anti-HEV IgG-maleimide modified CmagNP (Immuno-mal-CmagNP) product was purified by centrifugation, magnetically separated to remove unbound antibodies, and then incubated with 5% BSA to minimize non-specific interactions. Further magnetic separation was performed to remove excess BSA. Immuno-mal-CmagNP was redissolved in ultrapure DI water until use or stored in a refrigerator at 4°C.
[0069] The antigen-binding ability of the anti-HEV IgG antibody of Immuno-mal-CmagNP was confirmed using ELISA and quantified using a protein assay. Instead of anti-HEV IgG, Immuno-mal-CmagNP having an anti-NoV antibody and a maleimide functional group for detecting NoV-LPs / NoV was also prepared according to the same procedure.
[0070] <Preparation of pH-responsive nanogel> The pH-responsive nanogel (NG) was prepared by an oil-in-water emulsion process and using glutaraldehyde (GA) through the electrostatic interaction between polyethyleneimine (PEI) and tannic acid (TA) as cross-linking agents (Zou, Y., et al., 2019. Macromol. Biosci. 19, 1-11).
[0071] Specifically, 1 mL of PEI and 0.5 mg of TA were dissolved in a mixture of Triton X-100 (2 mL) and toluene (5 mL). After stirring the obtained mixture for 30 minutes, 0.5 mL of GA was added to the generated microemulsion, and it was further gently stirred for 12 hours. Thereafter, the obtained NG was precipitated using acetone and then washed with ethanol. The NG was redispersed in DI water and stored at 4 °C until use (Figure 6(a)).
[0072] <Preparation of SERS nanotag-nanogel> According to the procedures of Deka et al. (Deka, S.R., et al., 2010. Langmuir.26 (12) 10315-10324.) and Li et al. (Li, Y., et al., 2018.Biomacromolecules. 19(6) 2062-2070.), SERS nanotags were encapsulated within the pH-responsive nanogel (NG).
[0073] 50 μg / mL of NG and 0.5 mg / mL of 4-MBA-MoO in 1 mL of PBS (pH 7.0) 3 -QD were mixed, and the pH was adjusted to 4.5 with a few drops of 0.01 M HCl to induce the swelling of NG, change the permeability of NG, and enable the encapsulation of SERS nanotags. 0.01 M NaOH was added dropwise, and it was incubated for 1 hour with gentle stirring at 4 °C to slowly increase the pH of the reaction medium to 7.4 again. At pH 7.4, the reaction solution was left standing for about 1 hour to stabilize the NG encapsulated with SERS nanotags (hereinafter, sometimes referred to as "SERS nanotag@NG" or simply "loaded NG" in this specification).
[0074] <Fabrication of Immuno-SERS nanotag@NG> The prepared SERS nanotag@NG was conjugated with anti-HEV IgG according to the following method. 2 mL of EDC (0.1 M) was mixed with 10.1 μg of anti-HEV IgG antibody solution in 1 mL of PBS (pH 7.2) and stirred at ambient temperature for about 1 hour to generate an active ester intermediate with a carboxyl group of the antibody. Then, 2 mL of NHS (0.1 M) and 3 mL of supported NG (2 mg / mL) were added to the activated anti-HEV IgG antibody, and the mixture was stirred at 4 °C for 8 hours. To eliminate non-specific binding, 10% BSA solution was added to saturate the surface of anti-HEV IgG antibody-conjugated NG (sometimes referred to herein as "Immuno-SERS nanotag@NG" or "supported immuno-NG"), and the stock solution was stored at 4 °C until use. The anti-HEV IgG antibody conjugate was confirmed by ELISA, and the amount of anti-HEV IgG bound to the surface of NG was determined using the ninhydrin protein assay. Antibody-conjugated NG treated under the same conditions without SERS nanotag (sometimes referred to herein as "Immuno-NG") was used as a negative control in the immunoassay.
[0075] Instead of HEV, Immuno-SERS nanotag@NG for detecting NoV was also prepared in the same procedure using 20.5 μg of anti-NoV antibody.
[0076] <Fabrication of 2D hexagonal boron nitride SERS substrate> A solid substrate of 2D hexagonal boron nitride (h-BN) was prepared on the prepared glass slide by dropping and immobilizing the h-BN dispersion.
[0077] Specifically, a μ-quartz glass slide was immersed in 10 mL of acidic piranha solution (H 2 SO 4 / H 2 O 2The glass slides were immersed in a 3:1 ratio of [30%], followed by rinsing with deionized water and then ethanol. A stream of N2 gas was used to dry the glass slides, and then each slide was placed in a vacuum oven at 70 °C for 4 h. The h-BN dispersion was then deposited onto an oven-dried quartz slide, which was further placed in a vacuum oven at 70 °C for 8 h to obtain an h-BN coating.
[0078] Example 2: Assays and Results <MoO 3 -Surface chemistry of QDs Synthesized MoO 3 The surface chemical properties of the H-QDs were evaluated by X-ray photoelectron spectroscopy (XPS). The XPS results are shown in Figure 3. Figure 3 (a) shows the wide-scan XPS spectrum, and peaks with binding energies of 236.6 eV (Mo 3d), 285.25 eV (C 1s), 412.5 eV (Mo 3p), and 532.4 eV (O 1s) were confirmed in (a). Figure 3 (b) shows that the deconvoluted Mo 3d peak corresponds to the Mo of Mo. 5+ It was confirmed that a typical strong peak was observed at 236.42 eV, which is assigned to the oxidation state. 3 -QD Mo 6+ The state was observed at 238.05 eV.
[0079] MoO 3 The size of MoO-QDs was observed by TEM, and the TEM image is shown in Figure 4(a), and the size (particle diameter) distribution is shown in Figure 4(b). 3 The Zn-QDs were confirmed to be nanoscale dots with particle sizes (diameters) in the range of approximately 3-9 nm, and the average particle size was 6.05±1.2 nm. Furthermore, the hydrodynamic diameter (Dh) recorded using dynamic light scattering (DLS) was 5.7±3.3 nm, which is close to the TEM results.
[0080] MoO 3 The results of localized surface plasmon resonance (LSPR) of MoO-QDs are shown in Figure 5. 3-QD was confirmed to show typical LSPR absorption in the visible region at 674 nm.
[0081] <Properties of pH-responsive NG> Nanogel (NG) is known to have a 3D framework with a large number of internal cavities. When the morphology of the prepared NG was evaluated by TEM, it was found that the average particle size was about 200 ± 35 nm, and the NG was uniformly dispersed in a spherical form ((b) in Fig. 6). Also, the hydrodynamic diameter (Dh) of NG in an aqueous medium showed a Dh of about 257 nm with a polydispersity index value of 0.18, indicating that the NG was uniformly dispersed in the aqueous medium.
[0082] <Encapsulation / release of SERS Nanotags controlled by pH> The optimal loading (encapsulation) and release conditions of SERS nanotags were monitored and determined by TEM.
[0083] After mixing SERS nanotags with NG at pH 7.4, switching to pH 4.5, and then returning to pH 7.4 after 1 hour, TEM images were recorded. (b) in Fig. 6 shows untreated NG (empty NG) at pH 7.0, (c) shows NG loaded with SERS nanotags (SERS nanotag@NG) at pH 7.4, and (d) shows a TEM image showing the release of SERS nanotags (4-MBA-MoO 3 -QD) from SERS nanotag@NG at pH 4.5.
[0084] Compared with the untreated NG at pH 7.4 having a particle size of about 230 nm in (b), the particle size of NG loaded with SERS nanotags increased to about 286 nm in diameter in (c). Also, it was clearly confirmed from the image in (c) that the nanotags were completely encapsulated within the layer of NG. In the TEM image of nanotag-loaded NG (d) when the pH was returned to 4.5, it was confirmed that the particle size of NG increased to about 360 nm and the nanotags were released and / or dispersed around the outer layer, thus confirming the pH-responsive behavior of NG.
[0085] Furthermore, to evaluate NGs as chemical payload systems, pH-induced swelling and deswelling experiments were determined. For this, the pH of the NG solution was varied using 0.01 M HCl or NaOH. The resulting suspensions of NGs were followed using dynamic light scattering (DLS) at various pH values. The measurements of the transition hydrodynamic diameter (Dh) of NGs at each pH are shown in Figure 7(a). Figure 7(a) confirms that the Dh of NGs is strictly inversely proportional to their environmental pH.
[0086] Furthermore, the measurement results of the hydrodynamic volume (Vh) of NG at each pH are shown in Fig. 7(b). According to Fig. 7(b), the transition of the pH medium from pH 8 to the acidic level pH 4 caused a radical shift in the hydrodynamic volume (Vh) of the internal cavity of NG by about 6.0 × 10 2 nm 3 to 1.2 × 10 6 nm 3 The NGs showed a roughly 2000-fold increase in hydrodynamic volume (Vh) induced by a proportional increase in pH. At pH values between 4.0 and 9.0, a critical swelling transition of the NGs was observed, which depended on the surface charge of the NGs, which was determined by the ratio of PEI and TA precursors used in the synthesis.
[0087] The pH-responsive nanotag encapsulation / release was further observed using DLS and zeta potential analysis. The DLS results are shown in Figure 8. At pH 4.5, the Dh of nanotag-loaded NG was 350 nm, whereas that of untreated NG was 238 nm, confirming the difference in particle size between the two (Figure 8(a)). Meanwhile, at the optimal loading pH (7.4), the particle size was 380 nm. The kinetics of the surface charge of NG was also investigated by zeta potential analysis at different pH of the solution medium, which showed that the surface charge of NG was strictly dependent on the environmental pH (data not shown).
[0088] Conclusive evaluation of the pH-controlled encapsulation and release of nanotags was confirmed using UV-vis measurements. As shown in Figure 8(b), the MoO 3The characteristic plasmon absorption of MoO QDs was barely detectable in the NG loaded with SERS nanotags at pH 7.4 (optimal nanotag loading pH). This is due to the shielding of the nanotags as they were completely trapped and encapsulated within the cavity of the NG, as shown by the TEM image in Figure 6(c). On the other hand, when the pH was returned to 4.5, the MoO 3 Strong plasmonic absorption of the -QDs was observed, indicating the release of SERS nanotags from the encapsulation layer of NG.
[0089] <SERS immunoassay for target viruses> (Sandwich Protocol) The detection protocol is shown in Figure 2. HEV-LP detection in PBS (pH 7.6) or human serum medium was attempted. It was performed via an immunomagnetic virus capture / isolation step and a sandwich protocol. This method was highly beneficial for HEV detection especially in human serum and cell culture supernatant. The magnetically concentrated HEV-LP capture sandwich immune complex was used for pH-induced SERS immunoassay following an optimized pH control protocol. The SERS nanotag-loaded Immuno-NG was stable at pH 7.0-8.0, and therefore the immune reaction forming the sandwich complex at physiological pH 7.4 did not release the encapsulated nanotag. After changing the pH to 4.5, the NG released the nanotag from its cavity, and the subsequent SERS detection was performed on the 2D h-BN substrate. Here, the sandwich structure refers to a complex formed by binding the target substance, the virus, to both the antibody in Immuno-mal-CmagNP and the antibody in the SERS nanotag-loaded NG.
[0090] Maleimide-functionalized CmagNP (Immuno-mal-CmagNP) was compared with Immuno-CmagNP (control) that does not contain a maleimide moiety. In PBS (pH 7.0) or 50% human serum, 2 mL of Immuno-NG carrying SERS nanotags (Immuno-SERS nanotag@NG) was mixed with 1.5 mL of Immuno-mal-CmagNP, and HEV-LP (specific concentration can be determined each time, so it is not necessary to specify it here. In actual use, 10 to 10 6 fg / mL range. ) was added. Immuno-CmagNP was used as a control. The mixture was incubated for 30 min, and then the formed sandwich immune complex was collected using an external magnet. After washing three times with PBS, the resulting immune complex was resuspended in a solution of 1 mL of PBS (pH 7.0), and the pH was changed to 4.5 by adding 0.1 M HCl to release the encapsulated SERS nanotags. Then, the solution containing 50 μL of nanotag-loaded Immuno-NG / HEV-LP / Immuno-mal-CmagNP complex was transferred to a 2D h-BN-coated glass substrate placed in an external magnetic field for SERS measurements.
[0091] The SERS spectra of 4-MBA in the sandwich immunocomplex formed in the presence of Immuno-mal-CmagNPs or Immuno-CmagNPs are shown in Figure 9. The SERS signal of the SERS nanotag 4-MBA was observed in the maleimide-functionalized CmagNPs, whereas the SERS signal of 4-MBA was not observed in the CmagNPs without the maleimide moiety. It was demonstrated that the maleimide moiety mediates the binding of the SERS nanotags.
[0092] (SERS detection of Hepatitis E virus-like particles (HEV-LP)) Using HEV-LP, an optimal protocol for SERS-based HEV immunoassay was developed. The procedure was the same as the sandwich protocol described above.
[0093] Specifically, 2 mL of Immuno-NG loaded with SERS nanotags (Immuno-SERS nanotag@NG) was mixed with 1.5 mL of Immuno-mal-CmagNPs in PBS (pH 7.0) or 50% human serum, and various titers of HEV-LP (0 (no addition), 10 fg / mL, 100 fg / mL, 1 pg / mL, 10 pg / mL, 100 pg / mL, 1.0 ng / mL) were added to the mixture. After incubating the mixture for 30 min, the formed sandwich immune complex was collected using an external magnet. After washing three times with PBS, the resulting immune complex was resuspended in 1 mL of PBS (pH 7.0) solution, and the pH was changed to 4.5 by adding 0.1 M HCl to release the encapsulated SERS nanotags. Then, 50 μL of the solution containing the nanotag-loaded Immuno-NG / HEV-LP / Immuno-mal-CmagNP complex was transferred to a 2D h-BN-coated glass substrate placed in an external magnetic field for SERS measurement. The results of the SERS measurement are shown in Figure 10.
[0094] From Figure 10(a), it was confirmed that the signal response of the SERS nanotags (Raman band of 4-MBA) increased the Raman signal in a HEV-LP concentration-dependent manner, suggesting that more SERS nanotags were released and formed “hot spot” clusters with increasing concentration of target HEV-LP.
[0095] Based on the results in Figure 10(a), 1098 cm -1 A calibration curve (calibration plot of log-transformed SERS intensity vs. HEV-LP concentration) was constructed using the characteristic Raman bands of 4-MBA in (Figure 10(b)). The limits of detection (LOD) of HEV-LP were calculated to be approximately 6.5 fg / mL in PBS and approximately 89 fg / mL in human serum.
[0096] Additionally, a SERS immunoassay (in PBS) was performed using bare glass substrates without any coating. The results are shown in Figure 11(a). The limit of detection (LOD) for HEV-LP on bare glass was calculated to be 2.8 pg / mL. This is 10 times lower than the analytical sensitivity of the chemically SERS-active 2D h-BN substrate. 3 The LODs of 6.5 fg / mL (2D h-BN substrate) and 2.8 pg / mL (bare glass) were much lower, on the order of 10 2 Particles / mL and 10 5 This large difference in sensitivity corresponds to the HEV-LP detection capability of 1000 particles / mL. 3 This result was especially attributed to the synergistic SERS activity (electromagnetic and chemical mechanisms) of H-QDs and the 2D h-BN substrate. The results demonstrated the importance of the 2D substrate material in SERS enhancement via the contribution of the chemical mechanism in SERS-based detection.
[0097] (SERS detection of target virus G7HEV in clinical samples) To demonstrate the versatility of the developed SERS-based immunoassay technique, detection of the target virus G7HEV in clinical samples was performed. Thus, G7HEV extracted from cell culture supernatant was detected following the optimized detection protocol for HEV-LP.
[0098] Further washing steps and immunomagnetic separation / isolation in premixed medium were required to concentrate HEVs before SERS analysis. Detection of G7HEV from cell culture supernatants was achieved in 10 2 ~10 6 The R of the linear calibration curve (Figure 11(b)) using different concentrations of HEV was 1.0 RNA copies / mL, and an LOD of 87.3 RNA copies / mL was achieved. 2 The R value is 0.9929, which is a good value for detection on 2D h-BN substrates. 2 Thus, the clinical sample analysis results demonstrated the robustness and interference-free nature of the developed SERS-based immunoassay, which provides high sensitivity and selectivity for HEV detection in samples with complex matrices.
[0099] (SERS detection of Norovirus (NoV)) A similar method was used to detect clinical NoV (GII.3) extracted from feces of infected patients. 5 NoV could be detected in the range of RNA copies / mL down to the 10 RNA copies / mL level (Figure 12(a)). The samples used were compared with the sensitivity of commercially available kits for NoV assays based on ELISA and lateral flow immunoassay, and the results showed that the sensitivity was approximately 10 3 RNA copies / mL, and approximately 10 5 The results suggested that the assay of the present invention represents a major advance in the detection of NoV in clinical samples.
[0100] (Specific and selective detection of target viruses) Using the developed SERS-based immunoassay, the detection specificity of the target virus HEV-LP was investigated. Influenza virus A (H1N1 and H3N2), Zika, NoV-LP, and dengue DNA were separately tested for interference with the immunoassay. As a result, a stable SERS response was obtained regardless of the presence or absence of contaminants (Figure 12 (b)).
[0101] The results shown in Figure 12(b) show that target HEV detection was achieved with 5 × 10 of the tested biomolecules or viral RNA. 3 We showed that up to copies / mL can be achieved without interference.
[0102] (Demonstration of reproducibility and stability of detection) The developed SERS-based immunoassay was further tested and demonstrated its ability to generate reproducible SERS signals.
[0103] The average intensity of the SERS signals generated from more than 100 randomly sampled spots on the 2D h-BN substrate was collected (Figure 13 (a) and (b)). -1The intensity values / enhancement factors (EFs) of the 4-MBA Raman bands of the SERS nanotags in were used to calculate the relative standard deviation (RSD) of the signal from the average calculated intensity, which was further used to evaluate the uniformity and reproducibility of the SERS nanotag signal.
[0104] The results demonstrated that each spot could generate a strong SERS signal, albeit with some signal intensity fluctuation (Figure 13 (c) and (d)). Moreover, the calculated RSD was 5.95%, showing a deviation of less than 8%, indicating excellent spot-to-spot reproducibility of the SERS nanotags on the 2D h-BN substrate and the immunoassay process. Furthermore, the stability test of the developed SERS-based immunoassay was carried out over a period of one month, demonstrating that a reliable SERS signal could still be obtained within three weeks of the immunoassay without compromising its initial output (data not shown).
[0105] As mentioned above, we applied the nanogel technology, which is similar to an in vivo drug payload / delivery system, to the SERS detection of target substances such as viruses. To this end, we used plasmonic MoO as a novel SERS nanotag. 3 used mal-CmagQDs and exploited the pH-responsive behavior of nanogels (NGs) in the detection of Hepatitis E virus (HEV) or Norovirus (NoV). The pH-induced release of SERS nanotags encapsulated in the nanogels resulted in engineered localized SERS "hot spot" regions driven by the nanotag-maleimide binding affinity. By utilizing the magnetic properties of mal-CmagNPs for target substance concentration such as viruses, a magnetic pull-down / actuation process on 2D hexagonal boron nitride substrates was achieved, enhancing the SERS activity of the nanotags for detection.
[0106] With this strategy, the sensitivity of the developed SERS-based immunoassay was improved due to the synergistic contribution of the used nanotag / 2D substrate system, which is driven by the plasmonic MoO 3The SERS activity of the NG- or mal-CmagNPs was significantly increased to a threshold that could not be reached by the NG-QDs alone (on bare glass substrate). Furthermore, this developed SERS-based immunoassay can not only generate reproducible SERS signals for virus detection in clinical samples, but also detect various viruses by simply changing the antibodies on the NG or mal-CmagNPs. In particular, the nanogel-based protection strategy for SERS nanotags improves the stability and safety of SERS nanotags in complex environments, and further improvements in stability and safety are expected in the future.
Claims
1. A nanogel for detecting a target substance based on surface-enhanced Raman scattering (SERS), the nanogel containing an SERS nanotag therein, a specific probe for the target substance bound to the surface of the nanogel, and capable of releasing the nanotag outside the nanogel in response to a physical or chemical stimulus.
2. The nanogel of claim 1 , wherein the physical or chemical stimulus is selected from pH, temperature and light.
3. The nanogel according to claim 1 or 2, wherein the target substance is selected from proteins, nucleic acids, sugars, bacteria and viruses.
4. The nanogel according to any one of claims 1 to 3, wherein the target substance is a virus or a bacterium.
5. The nanogel according to any one of claims 1 to 4, wherein the probe is selected from an antibody, a nucleic acid probe, a lectin and an aptamer.
6. The nanogel according to any one of claims 1 to 5, for detecting a target substance in a test sample selected from urine, stool, blood, saliva, mucus, gastric juice, intestinal juice, mucous membrane, hair, cells, and tissues.
7. The nanogel of any one of claims 1 to 6, wherein the SERS nanotags are molybdenum trioxide quantum dots having 4-mercaptobenzoic acid bound to their surface.
8. A nanogel according to any one of claims 1 to 7, Surface-modified magnetic nanoparticles having specific probes for the target substance bound thereto; 1. A kit for surface-enhanced Raman scattering (SERS)-based detection of a target substance, comprising:
9. 9. The kit of claim 8, further comprising a two-dimensional substrate having a surface coated with hexagonal boron nitride.
10. A method for detecting a target substance based on surface-enhanced Raman scattering (SERS), using the nanogel according to any one of claims 1 to 7 or the kit according to claim 8 or 9.
11. (1) preparing the nanogel according to any one of claims 1 to 7 and magnetic nanoparticles having a surface modification and a specific probe for the target substance bound thereto; (2) contacting the nanogel and the magnetic nanoparticles with a sample that may contain the target substance to form a reaction complex containing the target substance, the nanogel, and the magnetic nanoparticles; (3) recovering the reaction complex using a magnet; (4) applying a physical or chemical stimulus to the reaction complex to release the SERS nanotag from the nanogel and form a SERS hotspot; (5) subjecting the reaction complex in which the SERS hot spot is formed to Raman scattering analysis on a SERS substrate to detect the presence of a target substance; The detection method according to claim 10, comprising:
12. The detection method according to claim 11, wherein the physical or chemical stimulus to the reaction complex is selected from pH, temperature and light.
13. 13. The detection method according to claim 11 or 12, wherein the SERS substrate is a two-dimensional substrate having a surface coated with hexagonal boron nitride.
14. (6) The detection method according to any one of claims 11 to 13, further comprising a step of quantifying the target substance with reference to a calibration curve previously prepared using a standard of the target substance.
Citation Information
Patent Citations
A method for enhancing nucleotide signals using Raman scattering.
JP2005519622A
Surface-enhanced Raman spectroscopy (sers) active composite nanoparticles, methods of manufacture and methods of use of the foregoing
JP2007502716A
Methods and apparatus for using Raman-active probe constructs to assay biological samples
JP2007524087A
Multiple detection probes
JP2007526999A
Tumor targeting and spectroscopic detection using surface-enhanced Raman nanoparticle tags in vivo
JP2010523983A
